The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
出版年份 2021 全文链接
标题
The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 19, Pages 10719
出版商
MDPI AG
发表日期
2021-10-04
DOI
10.3390/ijms221910719
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density
- (2021) Dita Ulase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival
- (2021) Zhi-guo Shan et al. Journal of Immunology Research
- Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer
- (2021) Zheng-Yan Li et al. CLINICAL IMMUNOLOGY
- Immunological role and underlying mechanisms of B7‐H6 in tumorigenesis
- (2020) Yuxuan Hu et al. CLINICA CHIMICA ACTA
- VISTA: Coming of age as a multi‐lineage immune checkpoint
- (2020) M. A. ElTanbouly et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- (2020) Luisa Barrueto et al. Translational Oncology
- Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
- (2020) Shenghua Zhan et al. Frontiers in Oncology
- Immunotherapy in gastrointestinal cancer: the current scenario and future perspectives
- (2020) Mohammed Abdul-Latif et al. CANCER TREATMENT REVIEWS
- Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer
- (2020) Yuko Nakayama et al. Gastric Cancer
- Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
- (2020) Julia Huetter et al. Cancer Immunology Research
- ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses
- (2020) Min Su et al. Cellular & Molecular Immunology
- VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
- (2020) Xing Huang et al. Journal of Hematology & Oncology
- Interferon‑γ induced PD‑L1 expression and soluble PD‑L1 production in gastric cancer
- (2020) Yushi Imai et al. Oncology Letters
- Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
- (2020) Anita Mazloom et al. Journal of Clinical Medicine
- Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
- (2019) Otília Menyhárt et al. Frontiers in Pharmacology
- Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
- (2019) Cong Chen et al. OncoImmunology
- Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
- (2019) Lujun Chen et al. Cancer Cell International
- Hypoxia-induced VISTA promotes the suppressive function of myeloid- derived suppressor cells in the tumor microenvironment
- (2019) Jie Deng et al. Cancer Immunology Research
- Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
- (2019) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
- (2019) Li Wei et al. Human Cell
- Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
- (2019) Florent Amatore et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors
- (2019) A. I. Chapoval et al. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
- Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
- (2019) Katsiaryna Marhelava et al. Cancers
- B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity
- (2019) Linlin Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Overexpression of B7H5/CD28H is associated with worse survival in human gastric cancer
- (2019) Can Hu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression
- (2018) Albert T. Gacerez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
- (2018) Yinghao Zhao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas
- (2018) Fengyuan Che et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway
- (2018) Donghui Zhou et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance
- (2018) Joseph R. Podojil et al. JOURNAL OF IMMUNOLOGY
- ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses
- (2018) Iris Hecht et al. JOURNAL OF IMMUNOLOGY
- The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
- (2018) Masataka Shimonosono et al. Oncotarget
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
- (2018) Y -J Bang et al. ANNALS OF ONCOLOGY
- Abstract CT111: Avelumab (anti-PD-L1) as first-line maintenance (1L mn) or second-line (2L) therapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): updated phase Ib results from the JAVELIN Solid Tumor trial
- (2018) Hyun Cheol Chung et al. CANCER RESEARCH
- Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
- (2018) Bin Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- VSIG-3 as a ligand of VISTA inhibits human T cell function
- (2018) Jinghua Wang et al. IMMUNOLOGY
- MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection
- (2018) Xiaoyu Zheng et al. ANNALS OF SURGICAL ONCOLOGY
- VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases
- (2018) Malte Borggrewe et al. GLIA
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Immune checkpoint blockade opens a new way to cancer immunotherapy
- (2018) Sanam Sadreddini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer
- (2018) Jayati Chakrabarti et al. Oncotarget
- HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer
- (2018) Rui Deng et al. Clinical Epigenetics
- Immunoregulatory functions of VISTA
- (2017) Elizabeth C. Nowak et al. IMMUNOLOGICAL REVIEWS
- New checkpoints in cancer immunotherapy
- (2017) Ling Ni et al. IMMUNOLOGICAL REVIEWS
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma
- (2017) Eiji Oki et al. ONCOLOGY
- B7-H3 promotes gastric cancer cell migration and invasion
- (2017) Yecheng Li et al. Oncotarget
- The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
- (2017) Christine Böger et al. OncoImmunology
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
- (2016) Elizabeth D Thompson et al. GUT
- Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma
- (2016) Min Dong et al. HUMAN PATHOLOGY
- CD28 Costimulation: From Mechanism to Therapy
- (2016) Jonathan H. Esensten et al. IMMUNITY
- ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
- (2016) Hirotsugu Nagase et al. INTERNATIONAL JOURNAL OF CANCER
- Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma
- (2016) FEIFEI WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Phase 3 KEYNOTE-061 study.
- (2016) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30
- (2016) Xiaoping Xu et al. JOURNAL OF MOLECULAR BIOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints
- (2016) Maria Alsina et al. Targeted Oncology
- Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
- (2016) Hyeyoon Chang et al. Oncotarget
- B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer
- (2016) YongHui Cui et al. MEDICAL SCIENCE MONITOR
- Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer
- (2016) Xiaojun Liu et al. Therapeutic Advances in Gastroenterology
- ICOS Co-Stimulation: Friend or Foe?
- (2016) Daniel J. Wikenheiser et al. Frontiers in Immunology
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- A New VISTA on combination therapy for negative checkpoint regulator blockade
- (2016) Jie Deng et al. Journal for ImmunoTherapy of Cancer
- Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation
- (2016) Patrícia Oliveira et al. Scientific Reports
- B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
- (2015) R. G. Veenstra et al. BLOOD
- Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy
- (2015) Gina B. Scott et al. CELLULAR IMMUNOLOGY
- A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
- (2015) Y. Xiao et al. CLINICAL CANCER RESEARCH
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
- (2015) Guoshuai Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human PD-1 binds differently to its human ligands: A comprehensive modeling study
- (2015) Clement Viricel et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53
- (2015) K. W. Yoon et al. SCIENCE
- HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
- (2015) Murali Janakiram et al. OncoImmunology
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance
- (2014) Yiting Geng et al. International Journal of Clinical Oncology
- Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity
- (2014) Dallas B. Flies et al. JOURNAL OF CLINICAL INVESTIGATION
- ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells
- (2014) Y. Burmeister et al. JOURNAL OF IMMUNOLOGY
- Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
- (2014) WEI DAI et al. ONCOLOGY REPORTS
- Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis
- (2014) Ninu Maskey et al. TUMOR BIOLOGY
- B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity
- (2014) R. Rahbar et al. Cancer Immunology Research
- The Immunological Synapse
- (2014) M. L. Dustin Cancer Immunology Research
- Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
- (2013) J. Matta et al. BLOOD
- Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses
- (2013) D. Dangaj et al. CANCER RESEARCH
- Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer
- (2013) Xiao-Mei Huang et al. CANCER SCIENCE
- Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2 - tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis
- (2013) T. Higashi et al. JOURNAL OF CELL SCIENCE
- A functional variant at miR-24 binding site in B7-H2 alters susceptibility to gastric cancer in a Chinese Han population
- (2013) Panpan Yang et al. MOLECULAR IMMUNOLOGY
- B7-H6 Protein Expression has no Prognostic Significance in Human Gastric Carcinoma
- (2013) Xiao-Juan Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
- (2013) R. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC
- (2012) Martin F. Flajnik et al. IMMUNOGENETICS
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
- (2012) Hiroaki Saito et al. JOURNAL OF SURGICAL ONCOLOGY
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts
- (2011) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
- (2011) Tomonori Kaifu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
- (2011) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- A frequent somatic mutation in CD274 3′-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding
- (2011) Weipeng Wang et al. HUMAN MUTATION
- B7-H2 Is a Costimulatory Ligand for CD28 in Human
- (2011) Sheng Yao et al. IMMUNITY
- ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6
- (2011) Youn Soo Choi et al. IMMUNITY
- Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
- (2011) Yili Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells
- (2011) Cheryl H. Rozanski et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
- (2011) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Significance of the B7-H4 Coregulatory Molecule as a Novel Prognostic Marker in Gastric Cancer
- (2011) Takaaki Arigami et al. WORLD JOURNAL OF SURGERY
- Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer
- (2010) Jingting Jiang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3
- (2010) Y. Tsukamoto et al. CANCER RESEARCH
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions
- (2010) Stefania Laurent et al. HUMAN IMMUNOLOGY
- Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis
- (2010) Takaaki Arigami et al. JOURNAL OF SURGICAL ONCOLOGY
- IL-10/TGF- -Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis
- (2010) Q. Cao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Roquin Differentiates the Specialized Functions of Duplicated T Cell Costimulatory Receptor Genes Cd28 and Icos
- (2009) Michelle A. Linterman et al. IMMUNITY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism
- (2009) Prasun J. Mishra et al. PLoS One
- Effector Functions of Donor-Reactive CD8 Memory T Cells Are Dependent on ICOS Induced During Division in Cardiac Grafts
- (2008) A. D. Schenk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
- (2008) C A Crane et al. ONCOGENE
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses
- (2008) M. Hashiguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings
- (2008) Marko Lens et al. Recent Patents on Anti-Cancer Drug Discovery
- Positional Cloning of “Lisch-like”, a Candidate Modifier of Susceptibility to Type 2 Diabetes in Mice
- (2008) Marija Dokmanovic-Chouinard et al. PLoS Genetics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More